6 The phosphodiesterase-five inhibitor sildenafil is certified for PAH in FC I–IV within the United states and FC II–III in Europe. Endothelin receptor antagonists (ERAs) like bosentan, sitaxentan and ambrisentan are oral therapies accredited for use in PAH. As no oral agent has shown superiority there stays discussion regarding which really sh… Read More